ISCT 2021 | Tackling therapeutic deception in unproven therapies: highlights from ISCT 2021
Laertis Ikonomou, PhD, University at Buffalo & The State University of New York, Buffalo, NY, provides an overview of a regulatory session set to take place at the ISCT Annual Meeting 2021 on unproven or unlicenced cell-based therapies and therapeutic deception. In this session, the multidisciplinary panel will discuss some of the deceptive practices used in direct-to-consumer marketing of unproven therapies and how regulatory agencies and legislators are working to address these issues at a national and international level. This interview took place during the International Society for Cell & Gene Therapy (ISCT) Annual Meeting 2021.
Disclosures
Laertis Ikonomou has written an expert report in a class action lawsuit filed against a business selling unproven stem cell-based interventions, and wrote the report on a pro bono basis.
